1. Overview
Erlotinib is a targeted cancer medication used to manage certain types of lung and pancreatic cancers. It works to slow down or stop the growth of cancer cells, helping patients control the disease.
2. How It Works
Erlotinib blocks a protein called epidermal growth factor receptor (EGFR), which signals cancer cells to grow and divide. By inhibiting this protein, it helps reduce tumor growth and progression.
3. Common Uses
- Non-small cell lung cancer (NSCLC) with EGFR mutations
- Pancreatic cancer (used with other treatments)
4. Key Benefits
- Targets cancer cells directly to help slow tumor growth
- Oral medication for daily use
- Can improve progression-free survival in eligible patients
5. Safety & Precautions
- Take exactly as prescribed; do not skip or double doses
- Monitor for side effects such as rash, diarrhea, or liver issues
- Inform your doctor about other medications or existing health conditions
- Regular follow-up and lab tests are recommended
6. Scientific Literature (External Links)
- Erlotinib in lung cancer: PubMed Link
- EGFR inhibition mechanism: PubMed Link
- Erlotinib in pancreatic cancer: PubMed Link
These details are compiled from publicly available scientific sources. MYMEDS.MD is not liable for clinical interpretation. Please consult a licensed medical practitioner for personalised guidance.
